NCT02989025View on ClinicalTrials.gov

Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 22, 2017

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
PregnancyPreeclampsia (PE)
Interventions
DRUG

17 OHPC

The study participant will be given 17 OHPC, 250mg IM at admission and every 7 days thereafter.

Trial Locations (1)

39216

RECRUITING

Winfred L. Wiser Hospital, Jackson

All Listed Sponsors
lead

University of Mississippi Medical Center

OTHER